QLTI – QLT Inc, is a Biotechnology company, engaged in development and commercialization of ocular products.
QLTI – QLT, Inc |
||
Fundamentals | Previously closed at | 1.43 |
Day’s high | 1.47 | |
Day’s low | 1.41 | |
P/E ratio | NA | |
EPS | -0.74 |
Analysts opinion | After a restructuring bout of several years, and cancelled merger attempts with Auxiliam Pharma and InSite Vision, QLT’s price had dropped 64%. Now, QLT and Aegerion have announced a strategic merger, resulting in a combined company named “Novelion Therepeutics”. Under the merger terms, 1 share of Aegerion will be given in return for 1.0256 shares of QLT. An investor syndicate will be purchasing $22 Million worth QLT stocks at $1.76 per stock. Analyst confidence meter, a proprietary algorithm of Stockal gives75% buy based on analyst ratings. |
Sentiments | The sentiment index is 200% positive according to Stockal proprietary algorithm. |
Social Media Pulse | The stock has 50% lower social media chatter than usual. |